Sera of patients infected by earlier lineages of SARS-CoV-2 are capable to neutralize later emerged variants of concern

Pauvolid-Corrêa, Alex; Caetano, Braulia Costa; Machado, Ana Beatriz; Ferreira, Mia Araújo; Valente, Natalia; Neves, Thayssa Keren; Geraldo, Kim; Motta, Fernando; Veloso, Valdiléa G.; Grinsztejn, Beatriz; Siqueira, Marilda Mendonça; Resende, Paola Cristina.
Artículo en Inglés | ARCA | ID: arc-56780

Documentos relacionados

  1. Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants.
  2. The Life of SARS-CoV-2 Inside Cells: Replication-Transcription Complex Assembly and Function.
  3. Deep mutational scanning identifies SARS-CoV-2 Nucleocapsid escape mutations of currently available rapid antigen tests.
  4. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants.
  5. SARS-CoV-2 variants evolve convergent strategies to remodel the host response.
  6. Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron.
  7. Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.
  8. Potent cross-reactive antibodies following Omicron breakthrough in vaccinees.
  9. Rapid Selection of Sotrovimab Escape Variants in Severe Acute Respiratory Syndrome Coronavirus 2 Omicron-Infected Immunocompromised Patients.
  10. Antibody evasion properties of SARS-CoV-2 Omicron sublineages.